Myometrial muscle cell membrane potential modulation

Myometrial muscle cell membrane potential modulation" is not a specific molecule, protein, or receptor but rather describes a physiological process involving the regulation of the electrical charge across the plasma membrane of myometrial smooth muscle cells. This process is fundamental to controlling uterine contractility and involves multiple molecular players—primarily ion channels such as potassium channels (notably large conductance voltage- and calcium-activated potassium [BK] channels), calcium channels, and other ion transporters[1][2][5][6]. These proteins collectively determine the resting membrane potential and modulate excitation-contraction coupling in myometrial cells. The modulation of myometrial cell membrane potential is crucial for maintaining uterine quiescence during pregnancy and enabling coordinated contractions during labor. Abnormalities in this regulatory system can contribute to reproductive disorders such as preterm birth or dysmenorrhea[3]. Therapeutic agents that target this process typically act on specific ion channels or signaling pathways involved in setting or altering the myometrial cell's electrical state. For example, drugs that open potassium channels can promote relaxation by hyperpolarizing the cell membrane, while those that block calcium influx can reduce contraction strength[1]. However, "myometrial muscle cell membrane potential modulation" itself does not refer to a single druggable target but rather an ensemble function resulting from several molecular components. In summary, this entry does not correspond to a canonical therapeutic target but instead refers broadly to an important physiological mechanism governed by multiple well-defined targets such as BK channel (KCNMA1), L-type calcium channel (CACNA1C), etc.[1][5].